ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Immunovant, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Immunovant, Inc. (Immunovant or the Company) (NASDAQ: IMVT ) for violations of the securities laws.
- The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Immunovant, Inc. (Immunovant or the Company) (NASDAQ: IMVT ) for violations of the securities laws.
- The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- Immunovant announced a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401" on February 2, 2021.
- The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.